In cancer cells, Bax activation by BH3 proteins is limited by the overexpression of anti-apoptotic proteins, such as Bcl-xL, leading us to investigate if Tom22 was still involved in Bax activation in the presence of Bcl-xL. The gene discussed is BCL2L1; the disease is cancer.